Loxo Oncology
Priced, Nasdaq: LOXOEarly-stage biotech developing targeted therapies to treat solid tumors.
Industry: Health Care
First Day Return: 0.0%
Early-stage biotech developing targeted therapies to treat solid tumors.
| IPO Date | 07/31/2014 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $68 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Stamford, CT, United States |
|---|---|
| Founded | 2013 |
| Employees at IPO | 9 |
| Website www.loxooncology.com | |
IPO News for Loxo Oncology
Loxo Oncology (LOXO) Performance
